Avances en Diabetología最新文献

筛选
英文 中文
En relación con el número extraordinario monográfico sobre insulina aspártica 关于天冬氨酸胰岛素的特别专刊
Avances en Diabetología Pub Date : 2012-09-01 DOI: 10.1016/j.avdiab.2012.08.004
Federico Relimpio Astolfi , Antonio Villafaina Barroso , A. Jesús Blanco Carrasco
{"title":"En relación con el número extraordinario monográfico sobre insulina aspártica","authors":"Federico Relimpio Astolfi , Antonio Villafaina Barroso , A. Jesús Blanco Carrasco","doi":"10.1016/j.avdiab.2012.08.004","DOIUrl":"https://doi.org/10.1016/j.avdiab.2012.08.004","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"28 5","pages":"Pages 120-121"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2012.08.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91714782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Lucha por sobrevivir, diabetes tipo 2 y obesidad. Respuesta del autor 挣扎求生,2型糖尿病和肥胖。作者的回答
Avances en Diabetología Pub Date : 2012-09-01 DOI: 10.1016/j.avdiab.2012.08.002
José Manuel Fernández-Real
{"title":"Lucha por sobrevivir, diabetes tipo 2 y obesidad. Respuesta del autor","authors":"José Manuel Fernández-Real","doi":"10.1016/j.avdiab.2012.08.002","DOIUrl":"https://doi.org/10.1016/j.avdiab.2012.08.002","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"28 5","pages":"Pages 119-120"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2012.08.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137191286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lucha por sobrevivir, diabetes tipo 2 y obesidad 挣扎生存,2型糖尿病和肥胖
Avances en Diabetología Pub Date : 2012-09-01 DOI: 10.1016/j.avdiab.2012.07.003
Federico Soriguer
{"title":"Lucha por sobrevivir, diabetes tipo 2 y obesidad","authors":"Federico Soriguer","doi":"10.1016/j.avdiab.2012.07.003","DOIUrl":"10.1016/j.avdiab.2012.07.003","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"28 5","pages":"Pages 118-119"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2012.07.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86922384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluación de nuevos criterios de osteoporosis en la diabetes tipo 2 2型糖尿病骨质疏松新标准的评估
Avances en Diabetología Pub Date : 2012-09-01 DOI: 10.1016/j.avdiab.2012.10.001
Pedro Rozas Moreno , Rebeca Reyes García , Antonia García Martín , Gema López Gallardo , Mariela Varsavsky , Manuel Muñoz Torres
{"title":"Evaluación de nuevos criterios de osteoporosis en la diabetes tipo 2","authors":"Pedro Rozas Moreno ,&nbsp;Rebeca Reyes García ,&nbsp;Antonia García Martín ,&nbsp;Gema López Gallardo ,&nbsp;Mariela Varsavsky ,&nbsp;Manuel Muñoz Torres","doi":"10.1016/j.avdiab.2012.10.001","DOIUrl":"https://doi.org/10.1016/j.avdiab.2012.10.001","url":null,"abstract":"<div><h3>Objective</h3><p>Recent data suggest new diagnostic criteria for osteoporosis in type 2 diabetes mellitus (T2DM): femoral neck Tscore below -1.9 in women and below -2.1 in men. Our objective was to evaluate the percentage of patients diagnosed with osteoporosis according to these new criteria in a population of T2DM patients, and to analyse if there were differences compared to the WHO criteria for osteoporosis.</p></div><div><h3>Material and methods</h3><p>Cross-sectional study including 78 T2DM patients. Bone mineral density (BMD) was evaluated by dual X-Ray absorptiometry (DXA, Hologic QDR 4500). The percentage of patients with osteoporosis was determined using the WHO criteria (T-score &lt;2.5) and also according to the new criteria. Data were processed and analysed with SPSS 15.0.</p></div><div><h3>Results</h3><p>Mean age was 57.8 years (57.8±6.4). According to the WHO criteria, 19% of patients had lumbar osteoporosis, 2.6% osteoporosis in femoral neck (FN), and 4% in total femur (TF). When the new criteria were used, 29% of patients had lumbar spine osteoporosis, 11.5% FN osteoporosis, and 10% TF osteoporosis (<em>P</em>&lt;.05 for all compared to WHO classification).</p></div><div><h3>Conclusions</h3><p>The application of the new criteria for diagnosis of osteoporosis in T2DM enables a higher number of cases to be identified, which can help to improve the assessment of fracture risk in T2DM.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"28 5","pages":"Pages 114-117"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2012.10.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91714783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
En relación con el número extraordinario monográfico sobre insulina aspártica 关于天冬氨酸胰岛素的特别专刊
Avances en Diabetología Pub Date : 2012-09-01 DOI: 10.1016/J.AVDIAB.2012.08.004
F. R. Astolfi, A. V. Barroso, A. J. Carrasco
{"title":"En relación con el número extraordinario monográfico sobre insulina aspártica","authors":"F. R. Astolfi, A. V. Barroso, A. J. Carrasco","doi":"10.1016/J.AVDIAB.2012.08.004","DOIUrl":"https://doi.org/10.1016/J.AVDIAB.2012.08.004","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"1 1","pages":"120-121"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88642794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
¿Son fiables los medidores de glucemia capilar? 毛细血管血糖仪可靠吗?
Avances en Diabetología Pub Date : 2012-09-01 DOI: 10.1016/j.avdiab.2012.09.003
Maria Luisa Casas Oñate, Dolores Montoya Martínez
{"title":"¿Son fiables los medidores de glucemia capilar?","authors":"Maria Luisa Casas Oñate,&nbsp;Dolores Montoya Martínez","doi":"10.1016/j.avdiab.2012.09.003","DOIUrl":"https://doi.org/10.1016/j.avdiab.2012.09.003","url":null,"abstract":"<div><h3>Objective</h3><p>To assess the reliability of the portable blood glucose meters most used in a Health Area.</p></div><div><h3>Methods</h3><p>A diagnostic test analysis was conducted in the Zone VIII Health Centre, Albacete Health Area. A total of 50 diabetic patients with different treatments, and who came to the Centre to perform an analytical control, were included in the study. Capillary blood samples were measured on the seven glucometers to study. The results were compared with venous blood tested in the reference laboratory of the Albacete General University Hospital. For the descriptive analysis, means and percentages were used, and the Student's t test for paired data and standard deviation for analytical comparisons of the means, with 95% confidence intervals and <em>P</em> <!-->&lt;<!--> <!-->.05.</p></div><div><h3>Results</h3><p>Of the 50 subjects who were included in the study, 48% were female, and the mean age was 59 years. The glucose readings ranged from 23<!--> <!-->mg/dL to 292<!--> <!-->mg/dL and with haematocrits between 36.4% and 53.8%. The mean differences between the results from the reference laboratory and the different glucometers were as follows: Contour Link<sup>®</sup> 6.30; Accu-Chek<sup>®</sup> Aviva 10.20; Glucocard<sup>®</sup> 10.32; Optium Xceed<sup>®</sup> 12.24; FreeStyle Freedom<sup>®</sup> 13.62; One Touch Ultra 2<sup>®</sup> 18.16; Breeze 2<sup>®</sup> –8.08.</p></div><div><h3>Conclusions</h3><p>Glucometers generally give reasonable results compared to those measured in venous blood, and are highly reliable for the self-monitoring diabetic patient.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"28 5","pages":"Pages 110-113"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2012.09.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90025637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Riesgos y beneficios del tratamiento de la hiperglucemia en el paciente hospitalizado no crítico 非危重住院患者高血糖治疗的风险和益处
Avances en Diabetología Pub Date : 2012-09-01 DOI: 10.1016/j.avdiab.2012.09.004
Marta Botella Serrano
{"title":"Riesgos y beneficios del tratamiento de la hiperglucemia en el paciente hospitalizado no crítico","authors":"Marta Botella Serrano","doi":"10.1016/j.avdiab.2012.09.004","DOIUrl":"https://doi.org/10.1016/j.avdiab.2012.09.004","url":null,"abstract":"<div><p>The prevalence of hyperglycemia in non-critical hospitalized patients is high, occurring in up to one third of patients not previously diagnosed with diabetes. Hyperglycemia increases hospital morbidity and mortality, the impact being greater in patients not known to be diabetics.</p><p>The effect of intensive treatment of hyperglycemia in non-critical hospitalized patients is unclear, the only proven benefit is the reduction in the risk of infection.</p><p>The current recommendation is to keep blood glucose levels &lt;140<!--> <!-->mg/dL, and to use the basal-bolus insulin therapy for the glycemic control during hospitalization. Although the fear of inducing hypoglycemia is one of the main causes of poor glycemic control, the evidence of its impact on hospital morbidity and mortality is very limited. Only spontaneous hypoglycemia at admission and is associated with increased hospital mortality.</p><p>There is an increased risk of iatrogenic hypoglycemia at discharge, so this should be carefully monitored.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"28 5","pages":"Pages 105-109"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2012.09.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91714784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respuesta a Relimpio et al. Respuesta a rellimpio等。
Avances en Diabetología Pub Date : 2012-09-01 DOI: 10.1016/j.avdiab.2012.08.003
Ignacio Conget, Marga Giménez, Javier Escalada
{"title":"Respuesta a Relimpio et al.","authors":"Ignacio Conget,&nbsp;Marga Giménez,&nbsp;Javier Escalada","doi":"10.1016/j.avdiab.2012.08.003","DOIUrl":"10.1016/j.avdiab.2012.08.003","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"28 5","pages":"Pages 121-122"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2012.08.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86116685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Evaluación de nuevos criterios de osteoporosis en la diabetes tipo 2 2型糖尿病骨质疏松新标准的评估
Avances en Diabetología Pub Date : 2012-09-01 DOI: 10.1016/J.AVDIAB.2012.10.001
P. Moreno, Rebeca Reyes García, Antonia Mª García Martín, G. Gallardo, M. Varsavsky, M. Torres
{"title":"Evaluación de nuevos criterios de osteoporosis en la diabetes tipo 2","authors":"P. Moreno, Rebeca Reyes García, Antonia Mª García Martín, G. Gallardo, M. Varsavsky, M. Torres","doi":"10.1016/J.AVDIAB.2012.10.001","DOIUrl":"https://doi.org/10.1016/J.AVDIAB.2012.10.001","url":null,"abstract":"","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"32 1","pages":"114-117"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81546064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factores organizativos y profesionales asociados con la prescripción correcta de glibenclamida para el manejo de la diabetes mellitus tipo 2 与格列本脲正确处方治疗2型糖尿病相关的组织和专业因素
Avances en Diabetología Pub Date : 2012-07-01 DOI: 10.1016/j.avdiab.2012.09.001
Luis Durán-Arenas , Guillermo Salinas-Escudero , Adriana Zubieta-Zavala , Rodrigo Zendejas-Villanueva , Jorge Zendejas-Villanueva
{"title":"Factores organizativos y profesionales asociados con la prescripción correcta de glibenclamida para el manejo de la diabetes mellitus tipo 2","authors":"Luis Durán-Arenas ,&nbsp;Guillermo Salinas-Escudero ,&nbsp;Adriana Zubieta-Zavala ,&nbsp;Rodrigo Zendejas-Villanueva ,&nbsp;Jorge Zendejas-Villanueva","doi":"10.1016/j.avdiab.2012.09.001","DOIUrl":"10.1016/j.avdiab.2012.09.001","url":null,"abstract":"<div><h3>Introduction</h3><p>In México, there is a high proportion of patients with uncontrolled type 2 diabetes mellitus (DM2), as well as multiple problems in the quality of prescribing in first contact medical care, despite the recommendations of the regulations, evidence-based guidelines, and international reports.</p></div><div><h3>Objective</h3><p>To analyze the factors associated with good prescribing of treatment for DM2.</p></div><div><h3>Material and methods</h3><p>Survey research methods with a random multi-stage cluster sampling. Two surveys were conducted with patients and physicians to assess prescription patterns in hospitals and ambulatory care clinics. A set of bivariate logistic regressions were carried out to assess the association of the prescription patterns with organizational and medical factors, and multiple logistic regression models were finally fitted.</p></div><div><h3>Results</h3><p>A total of 267 physicians were evaluated, of whom 39,62% were classified as prescribing correctly. Among the principal factors associated with correct prescription were, physician experience, to have specialty training, years since graduation from the specialty, and to have a clinical practice in more than one setting.</p></div><div><h3>Conclusions</h3><p>The results show the need to develop educational interventions to address the factors identified with good patterns of prescription for diabetes in Mexican hospitals and ambulatory clinics.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"28 4","pages":"Pages 95-101"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2012.09.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88730740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信